Evaluation of atrophy production and vasoconstrictor potency in humans following intradermally injected corticosteroids.
D000080:Acetals / Q000008:administration & dosage / Q000494:pharmacology; D000293:Adolescent; D000328:Adult; D001284:Atrophy; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000494:pharmacology; D007271:Injections, Intradermal; D007664:Ketosteroids / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D011246:Pregnadienetriols / Q000008:administration & dosage / Q000494:pharmacology; D011830:Radiation Effects; D012867:Skin / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects; D012880:Skin Pigmentation / Q000187:drug effects; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000494:pharmacology; D014466:Ultraviolet Rays; D014662:Vasoconstrictor Agents
D000080:Acetals; D005938:Glucocorticoids; D007664:Ketosteroids; D011246:Pregnadienetriols; D014662:Vasoconstrictor Agents; D014222:Triamcinolone Acetonide; D006854:Hydrocortisone